Use of cookies

Lund University uses cookies to ensure that the website functions properly and to improve your experience.

Read more in our cookie policy

Search results

Filter

Reset filter

Filetype

Your search for "*" yielded 572202 hits

Stockholm

6 juli 2020 Källa postnummerdata: Postnummerservice AB Karta med uppskattad förekomst av covid-19 i den vuxna befolkningen (20-79 år) i olika områden i Stockholms län, 6 juli 2020. Områdesindelningen är gjord utifrån de två första siffrorna i studiedeltagarnas postnummer. I Norrtälje har studien hittills färre än 500 deltagare, och därför kan man inte göra tillräckligt säkra beräkningar för att ku

https://www.covid19app.lu.se/kartor/kartor/stockholm/vecka-28/stockholm - 2026-10-13

Skåne

30 juni 2020 Källa postnummerdata: Postnummerservice AB Karta med uppskattad förekomst av symtomatyisk covid-19 i den vuxna befolkningen (20-79 år) i olika områden i Skåne, 30 juni 2020. Områdesindelningen är gjord utifrån de två första siffrorna i studiedeltagarnas postnummer. Ladda ned appen här

https://www.covid19app.lu.se/kartor/kartor/skane/vecka-27/skane-0 - 2026-10-13

Translational Neurology

Our research Neurovascular changes are now increasingly recognized as a common denominator of many neurodegenerative disorders. In my group, we examine how microvascular alterations at the blood-brain barrier contribute to the pathogenesis of neurodegeneration. Our special focus is on pericytes as key players in inflammation and neurodegeneration and potential target cells for brain repair. Using

https://www.multipark.lu.se/translational-neurology - 2026-10-13

Translational Neuroendocrinology

We study Huntington’s disease, the spectrum of amyotrophic lateral sclerosis, and the behavioral variant of frontotemporal dementia. These are all fatal neurodegenerative disorders without disease-modifying therapies.Although research has previously focused on the well-known disturbances in motor function, emerging studies point to early non-motor features with altered emotional processing and met

https://www.multipark.lu.se/translational-neuroendocrinology - 2026-10-13

Clinical Neurogenetics

Our group studies genetic factors that have a clinical impact on persons with Parkinson’s disease (PD). We examine patients and families with inherited forms of the disease (monogenic PD), as well as patients who develop PD early in life. Moreover, in a novel line of research, we explore whether combinations of variants in two different genes cause PD, a digenic disease mechanism.In a large popula

https://www.multipark.lu.se/clinical-neurogenetics - 2026-10-13

Stem Cell Laboratory for CNS Disease Modeling

Our research Research in the laboratory attempts to define pathogenic cellular and molecular mechanisms involved in synucleiopathies, in particular Parkinson's disease and multiple system atrophy, and Alzheimer's disease. Our work focuses on the interactions between glia and neurons. We are constantly developing new and robust human stem cell-based models which we utilize to understand cell autono

https://www.multipark.lu.se/stem-cell-laboratory-cns-disease-modeling - 2026-10-13

Laboratory for Experimental Brain Research

Our research Our research is focused on identifying cellular and molecular mechanisms contributing to circuit remodeling in the postischemic brain. In particular, we are interested in how the activation of dopamine signaling cascades modulates processes of adaptive neuronal plasticity. Identifying specific dopamine-driven targets may provide candidates for a recovery-enhancing adjuvant pharmacolog

https://www.multipark.lu.se/laboratory-experimental-brain-research - 2026-10-13

Translational Neurogenetics

We focus on finding protective factors for neurodegenerative disorders, with emphasis on Parkinson’s disease. Our strategy is to identify risk factors in genes, lifestyle and environment, to learn about the underlying causes of disease, and how to modify these.In this quest, we combine genetic, epigenetic and epidemiological studies in case-control cohorts on a local, regional and global scale. Ma

https://www.multipark.lu.se/translational-neurogenetics - 2026-10-13

Medial Temporal Lab

Our research focuses on aging and neurodegenerative diseases, aiming to improve understanding of disease mechanisms and support the development of biomarkers for clinical practice and clinical trials. We study fine-grained patterns of neurodegeneration, particularly in medial temporal lobe subregions that are affected early and selectively. Using structural MRI, imaging and biofluid markers, as we

https://www.multipark.lu.se/medial-temporal-lab - 2026-10-13

Regenerative Neurophysiology

Our research aims to generate specific subtypes of inhibitory brain cells, called interneurons, from human stem cells and patient-derived cells, using a technology known as neuronal reprogramming. Our goal is to develop interneuron cell replacement therapies for brain disorders. By reprogramming cells taken directly from patients, we create human disease-relevant models that allow us to investigat

https://www.multipark.lu.se/regenerative-neurophysiology - 2026-10-13

PET imaging in neurodegenerative diseases

We use positron emission tomography to elucidate disease mechanisms, monitor disease progression, and improve diagnosis in neurodegenerative disorders. Our group leads the PET imaging program within the BioFINDER studies, integrating tau PET, amyloid PET, dopamine transporter imaging, and cardiac sympathetic nervous system imaging. These modalities are combined with extensive biomarker profiling,

https://www.multipark.lu.se/pet-imaging-neurodegenerative-diseases - 2026-10-13

Clinical Memory Research Unit

We focus on developing accurate methods for the early diagnosis of neurodegenerative diseases, e.g., Alzheimer's and Parkinson's disease. Our research also aims to unravel the pathological events in humans during the pre-symptomatic and prodromal stages. Finally, we work to improve clinical trials evaluating new disease-modifying therapies. An overview of our research cohorts can be found at BioFI

https://www.multipark.lu.se/clinical-memory-research-unit-0 - 2026-10-13

Frontotemporal Dementia Research Unit

Frontotemporal dementia is the second most common neurodegenerative dementing disorder. Our research focuses on two main areas: improving the diagnostic process through the use of biomarkers and understanding the core mechanisms of the disease. To achieve these aims, we use a variety of methods, including PET, MRI, and genetic analyses.Our research contributes to improved diagnosis of frontotempor

https://www.multipark.lu.se/frontotemporal-dementia-research-unit - 2026-10-13